0001104659-20-000769.txt : 20200103
0001104659-20-000769.hdr.sgml : 20200103
20200103145517
ACCESSION NUMBER: 0001104659-20-000769
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191231
FILED AS OF DATE: 20200103
DATE AS OF CHANGE: 20200103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Prener Anne
CENTRAL INDEX KEY: 0001797917
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38586
FILM NUMBER: 20504759
MAIL ADDRESS:
STREET 1: C/O RUBIUS THERAPEUTICS
STREET 2: 399 BINNEY STREET SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rubius Therapeutics, Inc.
CENTRAL INDEX KEY: 0001709401
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042688109
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-679-9600
MAIL ADDRESS:
STREET 1: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
a4.xml
4
X0306
4
2019-12-31
0
0001709401
Rubius Therapeutics, Inc.
RUBY
0001797917
Prener Anne
C/O RUBIUS THERAPEUTICS, INC.
399 BINNEY STREET, SUITE 300
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (Right to Buy)
9.50
2019-12-31
4
A
0
50000
0
A
2029-12-30
Common Stock
50000
50000
D
This option shall vest in equal quarterly installments over the twelve quarters following the grant date.
/s/ Joanne M. Protano, Attorney-in-Fact
2020-01-03